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Hepadnavirus DNA polymerase functions in DNA synthesis and encapsidation, and acts as a primer for minus-strand DNA synthesis.
Through protein priming reaction, a short DNA oligomer synthesized from the bulge of epsilon (q) as template is covalently attached to the
Tyr residue in the terminal protein (TP) domain of DNA polymerase. Using endogenous polymerase assays and native agarose gel analysis,
we detected endogenous polymerase activity in priming-deficient mutant core particles, but not in reverse transcriptase (RT) reaction- or P
protein-deficient mutant core particles. In addition, priming-deficient mutant core particles incorporated radiolabeled 32P-dATP, 32P-TTP, and
32P-dGTP, but not 32P-dCTP. Our results suggest that the priming-deficient mutant P protein has the ability to synthesize oligomers
(presumably nascent minus-strand DNA) in the absence of covalent linkage between TP and the first deoxynucleotide. We propose that the
priming-deficient mutant may be defective in minus-strand DNA translocation to direct repeat (DR) 1 at the 3Vend of pregenomic RNA
(pgRNA) that leads to the elongation of minus-strand DNA.
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Hepadnaviruses are small, enveloped DNA viruses that
replicate preferentially in liver cells and are involved in
hepatocellular carcinoma (Wands and Blum, 1991). Hepa-
titis B virus (HBV), a prototype of hepadnavirus, has a
partially duplex relaxed circular DNA genome, which is
replicated by reverse transcription of the RNA genome to
produce DNA. Pregenomic RNA (pgRNA) serves as an
mRNA for capsid (C) and polymerase (P) proteins and as a
template for reverse transcription (Ganem and Schneider,
2001). Additionally, pgRNA is selectively encapsidated into
core particles with P protein (Bartenschlager and Schaller,
1992; Bartenschlager et al., 1990; Hirsch et al., 1990).
Hepadnavirus P, a multifunctional protein, plays a role in
HBV DNA synthesis and encapsidation of pgRNA (Bar-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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primer for minus-strand DNA synthesis (Wang and Seeger,
1992; Weber et al., 1994; Zoulim and Seeger, 1994). The P
protein has four domains, specifically, terminal protein (TP),
spacer, reverse transcriptase (RT), and RNase H. The TP
domain is covalently linked to minus-strand DNA upon
protein-primed initiation of reverse transcription (Bar-
tenschlager and Schaller, 1988; Radziwill et al., 1990; Wang
and Seeger, 1992; Weber et al., 1994; Zoulim and Seeger,
1994). The spacer region connects the TP and RT/RNase H
domains. This region is highly divergent between hepadna-
viruses and appears to be nonessential because substitution,
deletion, and insertion mutations are tolerated (Bartenschl-
ager and Schaller, 1988; Chang et al., 1990). RT and RNase
H regions of HBV polymerase display homology with RT of
retrovirus, which has an active and conserved motif for
RNA-dependent DNA polymerase (YMDD) and a con-
served RNase H motif (Chang et al., 1990; Hirsch et al.,
1990).
Hepadnavirus P protein recognizes the epsilon (q) se-
quence, which is the encapsidation signal of pgRNA. A P-q
ribonucleoprotein (RNP) complex is formed via structural
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1998; Tavis and Ganem, 1996; Tavis et al., 1998). It is
believed that chaperones and ATP assist the RNP complex
to adopt the right conformation for encapsidation, and the
priming reaction (initiation of reverse transcription) occurs
at this stage (Hu and Seeger, 1996; Hu et al., 1997). Before
or after the priming reaction, the RNP complex is recog-
nized and encapsidated by dimers of C proteins to form
core particles. Reverse transcription occurs inside the core
particle. Phosphodiester bonds are observed between the
hydroxyl group of Tyr in the TP domain and the first
nucleotide involved in the priming of reverse transcription
(Lanford et al., 1997; Weber et al., 1994; Zoulim and
Seeger, 1994). Three or two nucleotides are subsequently
copied from the bulge region of q to make TGAA or
GAA, the nascent minus-strand DNA. Following the syn-
thesis of nascent minus-strand DNA, the oligomer cova-
lently linked to the P protein translocates from q to direct
repeat (DR) 1 at the 3V end of pgRNA, leading to the
elongation of minus-strand DNA (Tavis and Ganem, 1995;
Tavis et al., 1994).
Mutations in the YMDD motif abolish reverse tran-
scriptase activity with no effect on pgRNA packaging
(Bartenschlager and Schaller, 1992; Bartenschlager et al.,
1990; Chang et al., 1990; Hirsch et al., 1990; Radziwill et
al., 1990; Roychoudhury et al., 1991). In DHBV, a
priming-deficient P protein (Tyr96 Phe mutant) forms a
P-q ribonucleoprotein (RNP) complex (Wang et al., 1994)
and encapsidates pgRNA into core particles in vivo
(Weber et al., 1994). The mutant DHBV P protein dis-
plays polymerase activity and synthesizes DNA from
exogenous RNA in vitro (the trans reaction) in an
epsilon- and template-dependent manner (Tavis et al.,
1998; Wang et al., 1994), although HBV DNA synthesis
is completely abolished (Tavis et al., 1998; Weber et al.,
1994). In view of these findings, it is suggested that DNA
synthesis occurs in the absence of the protein priming
reaction (Tavis et al., 1998; Wang et al., 1994). It is addi-
tionally suggested that the P protein (particularly the TP
region) is involved in minus-strand translocation (Gong et al.,
2000).
Using a new assay system that combines endogenous
polymerase assay (EPA) and native agarose gel analysis,
we demonstrate that a priming-deficient mutant P protein
inside core particles can synthesize oligomers from the
bulge region of q as a template in the absence of protein-
priming reaction. Our results indicate that priming-defi-
cient mutant P protein has polymerase activity. We suggest
that the covalent linkage between TP and the first nucle-
otide is not a prerequisite for initiating oligomer synthesis.
However, this linkage is required for the elongation of
minus-strand DNA synthesis via guiding nascent minus-
strand DNA to DR1 at the 3V end of pgRNA. Thus, it
appears that the priming-deficient mutant P protein is
defective in nascent minus-strand DNA translocation to
DR1.Results and discussion
HBV expression and pregenomic RNA encapsidation
To investigate the initiation of HBV DNA synthesis, we
prepared a HBV wild-type (wt) construct of subtype adw R9
(Blum et al., 1991) in which transcription of pgRNA is
controlled by a cytomegalovirus immediate early (CMV IE)
promoter. Next, a priming reaction-deficient TP Y65F mu-
tant involving the alteration of Tyr65 in the TP domain of P
protein to Phe was generated (Fig. 1). Additionally, P
protein-deficient and RT reaction-deficient RT YMHA
mutants were constructed in which the AUG start codon
was changed and frame-shifted, and the conserved YMDD
reverse transcriptase motif was modified to YMHA, respec-
tively (Fig. 1).
The in vitro priming reaction was abolished in the TP
Tyr96 Phe mutant of the DHBV P protein and Tyr96 has
been identified as the amino acid with which self-priming
occurs in DHBV P protein (Wang et al., 1994; Weber et al.,
1994; Zoulim and Seeger, 1994). Tyr63 of the HBV subtype
ayw P protein is involved in the in vitro priming reaction
with HBV P protein expressed using the baculovirus system
in insect cells (Lanford et al., 1997). Tyr65 of subtype adw of
the HBV P protein is homologous to Tyr63 of HBVayw and
Tyr96 of DHBV.
We initially analyzed HBV RNA expression in wt or
mutant-transfected HuH7 cells. Total RNA was analyzed by
Northern blot analysis and the RNase protection assay
(RPA). Upon transfection, pgRNA was expressed by the
action of the CMV promoter. Subgenomic RNA sequences
were synthesized under control of their authentic promoters.
The 3.5-kb pgRNA, and 2.1- and 2.4-kb mRNA sequences
of surface proteins were detected from wt or mutant-trans-
fected cells (Fig. 2A). There were no significant differences
in RNA expression levels between wt and mutant-transfected
cells (Fig. 2A).
We attempted to detect core particles by native agarose
gel electrophoresis and Western blotting using the anti-HBc
antibody (Koschel et al., 2000). Core particles were detected
from wt or mutant-transfected HuH7 cells that displayed
similar mobility on a native agarose gel (Fig. 2B). This
finding indicates that the P-deficient mutant can form core
particles in the absence of P protein and pgRNA. We
additionally show that wt, and priming and RT-deficient
mutants form core particles with similar rates. A greater
number of core particles were consistently detected from P-
deficient mutants (Fig. 2B). We speculate that the P protein
or RNP complexes downregulate core particle formation for
encapsidation.
RPA was conducted to detect cytoplasmic and encapsi-
dated pgRNA from wt, TP Y65F, or P-deficient mutant-
transfected HuH7 cells. Similar levels of cytoplasmic
pgRNA were observed in wt or mutant-transfected cells
(Figs. 2A and 2C, lower panel). The pgRNA from isolated
core particles were analyzed with RPA. Wt and TP Y65F
Fig. 1. Schematic diagram of HBV wt and mutant constructs used for transient expression. HBV sequences are depicted as thick lines and the q sequences at 5V
and 3Vends are marked. The ORFs of C, P, S, and X genes are presented as open boxes. Each domain (TP, spacer, RT, and RNase H) of the P protein is
indicated. The cytomegalovirus immediate early (CMV) promoter is represented by an open arrow. Mutant constructs, TP Tyr65 Phe mutant, P protein-
deficient, and RT YMDD to YMHA in a wt HBV adw R9 background are designated TP Y65F, P-deficient, and RT YMHA. The positions of P protein point
mutations are indicated as closed arrowheads.
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the P-deficient mutant was unable to encapsidate pgRNA
(Fig. 2C). This finding confirms that both P and C proteinsFig. 2. HBV RNA expression, core particle formation, pgRNA encapsidation, a
Northern blot analysis to detect HBV mRNA expression. Total RNAwas extracted
membranes, hybridized with random-primed 32P labeled HBV specific probes, and
for surface protein(s) are indicated. (B) Western blot analysis to detect core particle
membranes and incubated with rabbit HBc antibody. HRP-conjugated secondary an
(RPA) to detect HBV cytoplasmic pgRNA and encapsidated pgRNA. In vitro trans
at 50 jC with pgRNA from isolated core particles or 10 Ag total RNA. Pr
polyacrylamide–8 M urea gel and visualized by autoradiography. The upper pan
panel depicts cytoplasmic pgRNA. (D) Southern blot analysis to detect HBV DNA
transferred to nylon membranes, hybridized with a random-primed 32P-labeled
stranded, and partially double-stranded relaxed circular forms of HBV DNA are ma
used as a control marker.are required for encapsidation of pgRNA (Bartenschlager et
al., 1990; Hirsch et al., 1990). Our data (Fig. 2C) indicate
that priming-deficient mutant P proteins can encapsidatend DNA replication from HBV wt or mutant-transfected HuH7 cells. (A)
and separated by 1% formaldehyde gel electrophoresis, transferred to nylon
subjected to autoradiography. pgRNA (3.5 kb) and 2.1 and 2.4 kb mRNA
s from a native agarose gel. Isolated core particles were transferred to PVDF
tibody and ECL were used to visualize proteins. (C) RNase protection assay
cribed radiolabeled antisense RNA probe (446 nt) was hybridized overnight
otected pgRNA (369 nt) following RNase digestion was run on a 5%
el shows encapsidated pgRNA from isolated core particles while the lower
replication. HBV DNAwas extracted from isolated core particles, separated,
HBV specific probe, and subjected to autoradiography. Single-, double-
rked as SS, DS, and RC, respectively. HBV wt plasmid construct (1 ng) was
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1994). In view of earlier data that P proteins with mutations
at the conserved YMDD motif in the RT domain encapsidate
pgRNA (Bartenschlager and Schaller, 1992; Chang et al.,
1990; Radziwill et al., 1990; Roychoudhury et al., 1991), we
did not examine the RT YMHA mutant for encapsidated
pgRNA.
To investigate HBV DNA replication, cytoplasmic core
particles were isolated from HuH7 cells transfected with
HBV wt or mutants. Following extraction of HBV DNA
from isolated core particles, Southern blot analysis was
performed to detect replicating HBV DNA. Replicating
HBV DNA was only observed in wt core particles with
single-stranded, double-stranded, and partially double-
stranded relaxed circular HBV DNA (Fig. 2D). We did not
detect HBV DNA in TP Y65F, RT YMHA, or P-deficient
mutant-transfected cells (Fig. 2D). Theoretically, the P-
deficient mutant should be a dead virus. Due to the loss of
ability of priming-deficient mutants to form covalent link-
ages with nucleotides (Lanford et al., 1997; Wang and
Seeger, 1992; Weber et al., 1994; Zoulim and Seeger,
1994), the initial stage of replication was blocked in the
DHBV Y96F mutant, and consequently DNA replication did
not occur (Weber et al., 1994). Therefore, the HBV TP Y65F
mutant is deficient in both the priming reaction and DNA
replication. Mutation of the conserved reverse transcriptase
motif YMDD to YMHA results in a dead virus that does not
support HBV DNA synthesis in vivo (Chang et al., 1990;
Hirsch et al., 1990).
Endogenous polymerase activity of priming-deficient
mutant P protein
Previous studies show that the DHBV priming-deficient
mutant P protein synthesizes DNA from exogenous RNA in
vitro, suggesting that this P protein still displays polymerase
activity (Tavis et al., 1998; Wang et al., 1994), althoughFig. 3. Endogenous polymerase assay (EPA). (A) Isolated core particles from HB
buffer supplemented with 10 ACi of a-32 P-dATP (3000 Ci/mmol) and unlabeled d
agarose gel, and subjected to autoradiography. (B) Following EPA, 32P-labeled DN
to autoradiography. Single-, double-stranded, and partially double-stranded relaxedHBV DNA synthesis is completely abolished in vivo (Tavis
et al., 1998; Weber et al., 1994). In view of these results, it is
proposed that DNA synthesis can occur in the absence of
protein priming (Tavis et al., 1998; Wang et al., 1994).
To determine whether the priming-deficient mutant P
proteins of HBV have polymerase activity, we performed
EPA by incubating the isolated wt and mutant core particles
with 32P-dATP. Our rationale for this experiment is that free
nucleotides should pass through core particles freely (which
makes it possible to conduct EPA), but DNA or oligomers
cannot pass through core particles easily. Consequently,
radioactively labeled DNA or oligomers containing core
particles after EPA should be detected by autoradiography
following native agarose gel electrophoresis, but not core
particles with free radioactive 32P-dATP. After the EPA
reaction, reaction mixtures were electrophoresed on 1%
native agarose gels (Koschel et al., 2000) and subjected to
autoradiography. As expected, wt core particles were la-
beled with strong intensity (Fig. 3A). Surprisingly, TP
Y65F mutant core particles were labeled with signals that
were weak compared to wt, but strong enough to be
detected by autoradiography (Fig. 3A). We did not detect
radioactively labeled P-deficient or RT YMHA mutant core
particles (Fig. 3A). This finding is inconsistent with previ-
ously reported results showing that the priming-deficient
mutant has no endogenous polymerase activity (Bartenschl-
ager and Schaller, 1992; Tavis et al., 1998; Weber et al.,
1994). However, upon extracting 32P-labeled DNA from
core particles after EPA, we detected single-, double-strand-
ed, and partially double-stranded relaxed circular forms of
HBV DNA only from HBV wt, but not from TP Y65F, P-
deficient, and RT YMHA mutants (Fig. 3B). This finding is
in agreement with data from our Southern blot analyses
(Fig. 2D) and previous reports. We propose that the prim-
ing-deficient mutant P protein synthesizes the short oligo-
mer by incorporating 32P-dATP into core particles. Our data
collectively indicate that the TP Y65F mutant P proteinV wt or mutant-transfected HuH7 cells were incubated with EPA reaction
NTP mix at 37 jC for overnight incubation, electrophoresed on a 1% native
Awas extracted, separated by 1% agarose gel electrophoresis, and subjected
circular forms of HBV DNA are marked as SS, DS, and RC, respectively.
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synthesis.
Nascent minus-strand DNA synthesis by priming-deficient
mutant P protein
Because the priming-deficient mutant P protein is defec-
tive in HBV DNA synthesis due to loss of covalent linkage
between the first nucleotide and P protein, this mutant was
excluded in the analysis of HBV DNA synthesis initiation.
Previous studies attempted to identify HBV DNA from core
particles by Southern blotting, EPA, or primer extension
analyses.
Based on data on 32P-dATP-labeled TP Y65F mutant core
particles (Fig. 3A), we hypothesize that the short oligomer
synthesized from the bulge region of q template by the
priming-deficient mutant P protein may be TGAA or
GAA, despite the absence of covalent linkage between the
P protein and the first nucleotide. To confirm our theory, weFig. 4. Endogenous polymerase assay (EPA) to identify nucleotides in a short o
particles from HBV wt or mutant-transfected HuH7 cells were incubated with EP
unlabeled dNTP mixtures at 37 jC overnight. Reaction mixtures were electrophor
and priming-deficient mutant core particles were incubated with EPA reaction buff
mixtures with a certain dNTP omission at 37 jC overnight. To label the core particl
(3000 Ci/mmol) was used. Reaction mixtures were electrophoresed on a 1% agarconducted another EPA of isolated core particles with
different 32P-labeled nucleotides and unlabeled dNTP mix-
tures. Next, we analyzed labeled core particles on a native
agarose gel (Koschel et al., 2000). There were no significant
signaling differences among different 32P-labeled nucleoti-
des from wt core particles (Fig. 4A). We easily detected
priming-deficient mutant core particles labeled with 32P-
dATP, 32P-TTP, and 32P-dGTP, but not 32P-dCTP (Fig. 4A).
In one experiment, 32P-dCTP-labeled priming-deficient mu-
tant core particles were detected as a very faint band
following longer exposure times (data not shown). We
speculated that dCMP could be incorporated into the syn-
thesized oligomer with very low efficiency by copying the
bulge region of q (Fig. 5) because the oligomer synthesis was
arrested at this stage (Schaaf et al., 1999). In the case of
priming-deficient mutant, this arrest should be permanent
because this mutant could not elongate HBV DNA. We did
not detect labeled P-deficient and RT YMHA mutant core
particles with different 32P-labeled nucleotides (Fig. 4A).ligomer synthesized by the TP Y65F mutant P protein. (A) Isolated core
A reaction buffer supplemented with different 32P-labeled nucleotides and
esed on a 1% agarose gel and subjected to autoradiography. (B) Isolated wt
er supplemented with different 32P-labeled nucleotides and unlabeled dNTP
es, a-32P-dGTP (3000 Ci/mmol) was used. When we omit dGTP, a-32P-TTP
ose gel and subjected to autoradiography.
Fig. 5. Initiation of hepadnavirus minus-strand DNA synthesis. The P protein recognizes the overall structure of q of pgRNA, and RNA and protein undergo
conformational changes to facilitate encapsidation. Minus-strand DNA synthesis occurs at the bulge region of q as a template. A covalent linkage between the
Tyr residue in the TP domain and the first deoxynucleotide is formed and nucleotides are subsequently copied to TGAA or GAA. This complex is transferred to
DR1 at the 3Vend of pgRNAwhere minus-strand synthesis continues. Because newly synthesized oligomers are not covalently linked to TP in priming-deficient
TP Y65F mutant, this protein cannot translocate minus-strand DNA to DR1 at the 3V end of pgRNA.
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priming-deficient mutant P protein may be TGAA or GAA,
presumably nascent minus-strand DNA (Fig. 5).
Next, we performed another EPA reactions with wt and
priming-deficient mutant core particles with different 32P-
labeled nucleotides and unlabeled dNTP mixtures with
omission of a certain dNTP to demonstrate that the synthe-
sized oligomer by priming-deficient mutant P protein was
TGAA or GAA. Because it was not possible to extend wt
HBV DNAs in EPA reactions with one nucleotide omission,
the radiolabeled intensity of wt core particles was decreased
significantly (Fig. 4B). When we omitted dCTP, the radio-
labeled intensity of priming-deficient mutant core particles
was not decreased (Fig. 4B). Without dCTP, the radio-
labeled intensity of wt and priming-deficient mutant core
particles was similar (Fig. 4B). This result strongly supports
that the synthesized oligomer by priming-deficient mutant P
protein would be TGAA or GAA, the nascent minus-strand
DNA. As expected, we detected very faintly labeled prim-
ing-deficient mutant core particles when we omit TTP after
EPA reaction (Fig. 4B). We could not exclude the possibility
that these faintly labeled core particles without TTP might
be labeled by the endogenous dNTPs (see below). We
expected that we could not detect any radiolabeled prim-
ing-deficient mutant core particles when we omitted dATP
or dGTP. But when we omitted dATP or dGTP, we often
detected the priming-deficient mutant core particles as a
very faint band (Fig. 4B), which was a little bit controversial
to our hypothesis. In one experiment, we did not detect the
priming-deficient mutant core particles when we omitted
dATP or dGTP (data not shown). Then again, these core
particles were isolated from HBV wt and mutant-transfectedHuH7 cell lysates which contained the high concentration of
endogenous dNTP pool (Beck and Nassal, 1998), and it was
not possible to completely eliminate endogenous dNTP
from the lysate. By utilizing endogenous dNTPs, these core
particles could be labeled very faintly (Fig. 4B). But the
labeled intensity of these priming-deficient mutant core
particles was negligible compared to that of dCTP-omitted
core particles (Fig. 4B), which support our hypothesis.
Because priming-deficient mutant P protein can encap-
sidate pgRNA, it was generally admitted that the tertiary
structure of RNP complexes by wt and priming-deficient
mutant P protein would be the same. Therefore, it would be
unlikely to think that the oligomer was synthesized from the
other region of pgRNA as a template. After priming
reaction, the DNA synthesis is arrested (Schaaf et al.,
1999), then the translocation occurs to elongate HBV
DNA. During this process, it had been suggested that the
conformation of P protein or RNP complex might be
changed from a priming mode to an elongation mode (Gong
et al., 2000). Because priming-deficient mutant P protein of
DHBV could elongate DNA from exogenously added
template RNA (Tavis et al., 1998; Wang et al., 1994), it
would be reasonable to speculate that the priming-deficient
mutant P protein of HBV may still retain the ability to
elongate DNA.
Experiments with in vitro-expressed DHBV P protein
show that the protein-priming reaction is divided in two
stages, specifically, deoxynucleotide addition and elonga-
tion to synthesize nascent minus-strand DNA (Wang and
Hu, 2002). These two stages are independent processes and
possibly require different domains of the P protein (Wang
and Hu, 2002).
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linked to TP, we propose that the priming-deficient TP
Y65F mutant is defective in minus-strand translocation.
Moreover, the P protein covalently linked with the oligomer
functions to guide this nascent minus-strand DNA to DR1 at
the 3V end of pgRNA for elongation of minus-strand HBV
DNA (Fig. 5). It is reported that the DHBV TP region
deletion mutant P protein has reduced ability in minus-
strand translocation (Gong et al., 2000). Our data suggest
that the covalent linkage through the Tyr residue of P
protein and oligomer is a key element in this process.
In this study, we show that priming-deficient mutant
HBV P protein can synthesize oligomers without covalent
linkage between the Tyr residue of TP and the first deox-
ynucleotide. Moreover, covalent linkage may not be a
prerequisite for the initiation of oligomer synthesis. This
raises a very important question whether this P protein may
have features of the RNA polymerase. This issue is beyond
our reach, but it had been suggested that the DHBV P
protein has several features that are parallel to T7 RNA
polymerase (Schaaf et al., 1999). Also, it had been shown
that the RT of DHBV P protein could bind NTP into its
dNTP-binding pocket even with a single amino acid change
to amino acids with small side chain in the dNTP-binding
pocket region to provide the binding space for NTPs (Beck
et al., 2002). With further studies, the unique features of
hepadnavirus P protein may be elucidated.
A novel assay system has been developed to detect the
initiation of HBV DNA replication inside core particles by
combining EPA and native agarose gel analysis (Koschel et
al., 2000). Using this system, it is possible to analyze
numerous hepadnavirus DNA replication-deficient mutants
that are reported to have no polymerase activity by conven-
tional EPA.Materials and methods
DNA construction
HBV subtype adw R9, 1.3 length of the HBV genome
(Blum et al., 1991), was used to generate the partially
redundant HBV construct. The 1.3 length of HBV adw R9
construct was cloned into pGEM4Z, yielding pGEM HBV.
Next, the 5Vend of HBV (from nucleotides 1418–1818) was
deleted by PCR-derived mutagenesis. The 3Vend (a total of
225 nucleotides) was additionally deleted by PCR-derived
mutagenesis. To express HBV under the cytomegalovirus
immediate early (CMV IE) promoter, partially redundant
3.37 kb of HBV was cloned into pcDNA3 (Invitrogen). For
increasing encapsidation efficiency, 55 nucleotides of the
pcDNA3 sequence were deleted (Jeong et al., 2000) by PCR-
derived mutagenesis. The resulting construct encompassing
wild-type (wt) HBV subtype adw R9 was designated pPB.
Tyr65 (TAT) in the TP domain of P protein was
modified to Phe (TTT) by site-directed mutagenesis usinga fusion PCR technique. The oligonucleotides employed
were HBV15 (5V-GGTACTGTAGAGGAAAAAAGCC-
CAGTAAAG-3V), a forward mutagenic primer that targets
nt 2488–2517 and the reverse primer HBVc (5V-GGTCTC-
TTTCGGAGTGTGG-3V) that binds nt 2259–2277 of the
HBV genome. In another PCR reaction, the oligonucleotides
used included reverse mutagenic primer HBV14 (comple-
mentary to HBV15) and forward primer HBVPS1 (5V-
GAATCCCAGAGGGTTGGGAAC-3V) that binds nt
2907–2927 of the HBV genome. The resulting 0.26- and
0.44-kb products were combined for fusion PCR. The fusion
PCR product was digested with BspEI and BstEII, and cloned
among the corresponding restriction sites of pPB, yielding the
priming-deficient HBV TP Y65F mutant.
To generate a P protein-deficient mutant of HBV, the P
gene was frame-shifted and the AUG start codon was
modified to ACG with a silent mutation in C ORF. To
modify AUG to ACG, PCR was performed with the forward
mutagenic primer HBV24 (5V-GTTTCCGGAAGTGTTGA-
TAAGATAGGGGCGTTTGGTGGTC-3V) specific for nt
2301–2339 of HBV and reverse primer PC3 (5V-GCAGTA-
CATCAAGTGTAT-3V) which binds to the CMV promoter
region of pcDNA3. The PCR fragment was digested with
BspEI and SnaBI, and cloned among the corresponding
restriction sites of pPB, resulting in pPB ACG. To introduce
a frame-shift mutation, pPB ACG was digested with BstEII
and incubated with T4 DNA polymerase to fill in the 5Vend,
yielding a HBV P protein-deficient mutant.
For constructing the RT reaction-deficient RT YMHA
mutant of HBV, the conserved YMDDmotif was modified to
YMHA by site-directed mutagenesis using a fusion PCR
technique. The following oligonucleotides were used in the
PCR reaction: HBV40 (5V-CTTGGCCCCCAATACCA-
CAGCATGCATATAGCTGAAAGCCAAAC-3V), forward
mutagenic primer specific for nt 722–765 and reverse primer
HBV2 (5V-GCGGGTCACCATATTCTTGG-3V) that targets
nt 2820–2839 of the HBV genome. In another PCR reaction,
oligonucleotides used were reverse mutagenic primer
HBV39 (complementary to HBV40) and forward primer
HBV9 (5V-GCGAGAGGACGACAGAATTG-3V) which tar-
gets nt 1335–1354 of the HBV genome. The resulting 1.17-
and 0.63-kb PCR products were combined for fusion PCR.
The fusion PCR product was digested with EcoRI and
EcoRV, and cloned into the corresponding restriction sites
of pPB, yielding a HBV RT YMHA mutant. All constructs
were sequenced to confirm the presence of specific muta-
tions and to ensure that no extraneous mutations were
introduced during PCR.
Cell culture and transfection
HuH7 hepatoma cell lines were used for the transfection
of HBV wt and mutant clones. HuH7 cells were maintained
in Dulbecco’s modified eagle’s medium supplemented with
penicillin and streptomycin, and 10% fetal bovine serum.
HBV wt and mutant plasmids (8 Ag) were transfected into
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gen) according to the manufacturer’s instructions.
Isolation of core particles
Three days after transfection, HuH7 cells were lysed in 1
ml TNE (10 mM Tris–HCl [pH 8.0], 50 mM NaCl, 1 mM
EDTA)–1% Nonidet P-40. The clarified lysate was adjusted
with 10 mMMgCl2 and 8 mMCaCl2 solution, and incubated
overnight at 37 jC with 20 U DNase I (Sigma) and 60 U
micrococcal nuclease (Calbiochem). Cytoplasmic core par-
ticles were precipitated with 6.5% polyethylene glycol.
RNase protection analysis (RPA)
To analyze encapsidated pgRNA, core particles were
isolated as described above. pgRNA from core particles
was extracted following proteinase K (100 Ag/ml) and
DNase I (20 U) treatment. To analyze cytoplasmic pgRNA,
total RNA was extracted with RNA stat 60 (Tel-test, Inc.).
To prepare riboprobe for RPA, part of the HBV sequence (nt
1805–2187) was cloned into pGEM3Zf(+) vector, generat-
ing pRPAFD. From this construct, 446 nt of radiolabeled
anti-sense probe was synthesized in vitro using SP6 RNA
polymerase with a-32P-UTP (specific activity, 800 Ci/
mmol). The RPA procedure was performed using the
manufacturer’s protocol (RPA II, Ambion). The protected
pgRNA was 369 nt long.
Northern and Southern blotting
Total RNA (10 Ag) was denatured and electrophoresed
on a 1% agarose gel containing formaldehyde and blotted
onto a nylon membrane. RNA on the membrane was
hybridized to a 32P-labeled random-primed probe specific
for the HBV sequence or GAPDH cDNA. To analyze HBV
DNA synthesis by Southern blotting, core DNA was
extracted, separated by agarose gel electrophoresis, and
hybridized to a 32P-labeled random-primed probe specific
for the HBV sequence.
Western blotting
Isolated core particles were electrophoresed on a 1%
native agarose gel (Koschel et al., 2000). Core particles
were transferred to polyvinylidene fluoride (PVDF) mem-
branes as described for Northern blot analysis. Immuno-
blotting was performed using an anti-HBc antibody
(DAKO). Horseradish peroxidase-conjugated anti-rabbit
secondary antibody and enhanced chemical luminescence
(ECL) were employed to visualize HBV core particles.
Endogenous polymerase assay (EPA)
Isolated core particles were incubated at 37 jC overnight
with EPA reaction buffer (50 mM Tris–HCl [pH 7.5], 75mM NH4Cl, 1 mM EDTA, 25 mM MgCl2, 0.1% h-mercap-
toethanol, 0.5% Nonidet P-40) supplemented with 0.5 mM
each of dCTP, dGTP, and TTP, and 10 ACi a-32P-dATP
(3000 Ci/mmol). 32P-labeled reaction mixtures were electro-
phoresed on a 1% agarose gel and subjected to autoradiog-
raphy. 32P-labeled DNA was extracted following the EPA
reaction and separated by 1% agarose gel electrophoresis.
EPA was additionally performed using 10 ACi a-32P-dCTP,
a-32P-dGTP, a-32P-TTP, or a-32P-dATP with unlabeled
dNTP mixtures. EPA was also performed using 10 ACi
a-32P-dGTP or a-32P-TTP with unlabeled dNTP mixtures
with a certain nucleotide omission.Acknowledgments
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